Condor Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.89M | Sell |
6,502
-26
| -0.4% | -$11.6K | 0.25% | 86 |
|
|
2025
Q1 | $3.16M | Hold |
6,528
| – | – | 0.29% | 77 |
|
|
2024
Q4 | $2.63M | Sell |
6,528
-30
| -0.5% | -$12.1K | 0.23% | 91 |
|
|
2024
Q3 | $3.05M | Sell |
6,558
-41
| -0.6% | -$19.1K | 0.27% | 78 |
|
|
2024
Q2 | $3.09M | Sell |
6,599
-281
| -4% | -$132K | 0.3% | 78 |
|
|
2024
Q1 | $2.88M | Sell |
6,880
-143
| -2% | -$59.8K | 0.28% | 83 |
|
|
2023
Q4 | $2.86M | Sell |
7,023
-75
| -1% | -$30.5K | 0.31% | 80 |
|
|
2023
Q3 | $2.47M | Buy |
7,098
+7
| +0.1% | +$2.43K | 0.3% | 73 |
|
|
2023
Q2 | $2.5M | Sell |
7,091
-135
| -2% | -$47.5K | 0.3% | 72 |
|
|
2023
Q1 | $2.28M | Buy |
7,226
+4
| +0.1% | +$1.26K | 0.29% | 77 |
|
|
2022
Q4 | $2.09M | Buy |
7,222
+36
| +0.5% | +$10.4K | 0.26% | 87 |
|
|
2022
Q3 | $2.08M | Sell |
7,186
-234
| -3% | -$67.8K | 0.27% | 84 |
|
|
2022
Q2 | $2.09M | Buy |
7,420
+131
| +2% | +$36.9K | 0.27% | 82 |
|
|
2022
Q1 | $1.9M | Buy |
7,289
+3,251
| +81% | +$848K | 0.21% | 101 |
|
|
2021
Q4 | $887K | Sell |
4,038
-3,433
| -46% | -$754K | 0.1% | 138 |
|
|
2021
Q3 | $1.36M | Buy |
7,471
+219
| +3% | +$39.7K | 0.14% | 126 |
|
|
2021
Q2 | $1.46M | Sell |
7,252
-21
| -0.3% | -$4.23K | 0.16% | 118 |
|
|
2021
Q1 | $1.56M | Buy |
+7,273
| New | +$1.56M | 0.19% | 107 |
|